179 related articles for article (PubMed ID: 32179532)
1.
Rodriguez F; John SF; Iniguez E; Montalvo S; Michael K; White L; Liang D; Olaleye OA; Maldonado RA
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179532
[No Abstract] [Full Text] [Related]
2. Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.
Koutsoni OS; Karampetsou K; Kyriazis ID; Stathopoulos P; Aligiannis N; Halabalaki M; Skaltsounis LA; Dotsika E
Phytomedicine; 2018 Aug; 47():143-150. PubMed ID: 30166099
[TBL] [Abstract][Full Text] [Related]
3. Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis.
Badirzadeh A; Heidari-Kharaji M; Fallah-Omrani V; Dabiri H; Araghi A; Salimi Chirani A
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007843. PubMed ID: 31929528
[TBL] [Abstract][Full Text] [Related]
4. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase.
Onyenaka C; Idowu KA; Ha NP; Graviss EA; Olaleye OA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138972
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
6. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
7. Study of the
Azadi R; Alipour-Talesh G; Yazdanpanah MJ; Alavizadeh SH; Maleki M; Banihashemi M; Jaafari MR
J Vector Borne Dis; 2020; 57(1):78-84. PubMed ID: 33818460
[TBL] [Abstract][Full Text] [Related]
8. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
Abamor ES; Allahverdiyev AM; Bagirova M; Rafailovich M
Acta Trop; 2017 May; 169():30-42. PubMed ID: 28111133
[TBL] [Abstract][Full Text] [Related]
9. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
Moosavian SA; Fallah M; Jaafari MR
Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
11. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
[TBL] [Abstract][Full Text] [Related]
12. Discovery and Validation of Lmj_04_BRCT Domain, a Novel Therapeutic Target: Identification of Candidate Drugs for Leishmaniasis.
Peña-Guerrero J; Fernández-Rubio C; Burguete-Mikeo A; El-Dirany R; García-Sosa AT; Nguewa P
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638841
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Immunotherapeutic Potential of Oleocanthal against Murine Cutaneous Leishmaniasis.
Karampetsou K; Koutsoni OS; Badounas F; Angelis A; Gogou G; Skaltsounis LA; Halabalaki M; Dotsika E
Planta Med; 2022 Aug; 88(9-10):783-793. PubMed ID: 35803258
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major.
Bemani E; Oryan A; Bahrami S
Exp Parasitol; 2019 Oct; 205():107747. PubMed ID: 31442454
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB/c mice946.
Rahimi S; Rafinejad J; Akhavan AA; Ahmadkhaniha R; Bakhtiyari M; Khamesipour A; Akbarzadeh K
Parasit Vectors; 2023 Feb; 16(1):72. PubMed ID: 36797798
[TBL] [Abstract][Full Text] [Related]
17. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
[TBL] [Abstract][Full Text] [Related]
18. Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis.
Van Bocxlaer K; Caridha D; Black C; Vesely B; Leed S; Sciotti RJ; Wijnant GJ; Yardley V; Braillard S; Mowbray CE; Ioset JR; Croft SL
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():129-138. PubMed ID: 30922847
[TBL] [Abstract][Full Text] [Related]
19. The Therapeutic Effects of Curcumin-coated Gold Nanoparticle Against Leishmania Major Causative Agent of Zoonotic Cutaneous Leishmaniasis (ZCL): An In Vitro and In Vivo Study.
Amini SM; Hadighi R; Najm M; Alipour M; Hasanpour H; Vosoogh M; Vosough A; Hajizadeh M; Badirzadeh A
Curr Microbiol; 2023 Feb; 80(4):104. PubMed ID: 36781499
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Determination of Antileshmanial Activities of Benzimidazolium Derivatives on L. major Promastigotes and Amastigotes.
Kelleci K; Gölebatmaz E
Acta Parasitol; 2023 Mar; 68(1):51-55. PubMed ID: 36348181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
